Back to search
Pseudohypoparathyroidism Type 1A
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Pseudohypoparathyroidism Type 1A trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Pseudohypoparathyroidism Type 1A trials you may qualify forWe, the researchers, are following the natural history of Albright hereditary osteodystrophy. We have found that growth hormone deficiency is very common in pat…
The study evaluates the effect of theophylline in 100 subjects with Pseudohypoparathyroidism.
It is increasingly recognized that Pseudohypoparathyroidism type 1A (PHP1A) is associated with an increased risk of type 2 diabetes but the mechanism is unknown…
Pseudohypoparathyroidism is a genetic disorder with limited treatment options. Patients have early-onset obesity, short stature and increased risk of type 2 dia…
Pseudohypoparathyroidism is a genetic disorder with limited treatment options, characterized by early-onset obesity, short stature and resistance to multiple ho…